57 /100
HIGH RISK
Score updated Jul 14, 2026

CURX — Curanex Pharmaceuticals Inc Dilution Risk Tracker

Track CURX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CURX — Get alerts when the score changes →

As of July 14, 2026, Curanex Pharmaceuticals Inc (CURX) has a DilutionWatch DilutionScore of 57/100, rated HIGH dilution risk. Curanex Pharmaceuticals Inc has a market capitalization of $9.43M, 28.36M shares outstanding, 9 institutional holders tracked. Key dilution vectors include approximately 5 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
62
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
45%
🔄 Reverse Split 70%
• 50-day avg $0.41 below $1 exchange minimum
• Only 5 months cash — financial pressure
💰 Capital Raise 35%
• Low cash runway: 5 months remaining
🔔 Track CURX — Get forecast alerts →

💹 Market Data

Market Cap$9.43M
Shares Outstanding28.36M
Float8.91M
Cash$4.00M
Debt$476.5K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 21.8% shares (2026Q1 vs prior)
9 institutional holders · 332.4K shares
#1 GEODE CAPITAL MANAGEMENT, LLC 111.1K shares
#2 TWO SIGMA SECURITIES, LLC 56.7K shares
#3 XTX Topco Ltd 51.3K shares
+ 6 more holders Sign up free to view →

📉 Short Interest

Short Interest20.8K
Days to Cover1.0
% of Float0.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for CURX Shareholders

Curanex Pharmaceuticals Inc (CURX) has a DilutionScore of 57/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: CURX has approximately 5 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for CURX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CURX alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CURX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CURX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CURX
📊 CURX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CURX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.